Endocrinology
Partner With Us
Advertisement
Conexiant chevron_right Endocrinology chevron_right Weight Loss Showdown Pills or Scalpel
Conference News ASMBS 2025 Annual Meeting

Weight Loss Showdown: Pills or Scalpel?

A large analysis presented at the ASMBS Annual Meeting found bariatric surgery led to greater long-term weight loss than GLP-1 medications semaglutide and tirzepatide over three years.

Conexiant
Full Article Summary Notecard
  1. Study presented at the ASMBS Annual Meeting compared long-term weight loss outcomes between bariatric surgery and GLP-1 receptor agonist therapies.
  2. Bariatric surgery led to significantly greater and sustained weight loss over three years.
  3. GLP-1 patients had higher rates of diabetes, hyperlipidemia, and chronic obstructive pulmonary disease.
  4. The findings support bariatric surgery as a more effective strategy for managing obesity and metabolic disorders.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.